The U.S. CDC's National Center for Immunization and Respiratory Diseases reported yesterday the updated number of Persons Under Investigation (PUI) in the USA had reached 246. As of June 1, 2022, this data indicates a 13% increase of 30 additional children infected by an acute liver inflammation of unknown etiology in one week. CDC staff confirmed there had been multiple liver transplants and related fatalities.
According to a statement from Macao SAR Health Service translated today, two new cases of human infection with H9N2 avian influenza were confirmed in Hunan and Guizhou provinces. According to the report issued on June 2, 2022, one of the patients is a 5-year-old boy who lives in Yueyang City, Hunan Province. His condition is mild, and there were live poultry market activities before the onset of the disease.
Osaka-based Takeda Pharmaceutical Company Limited and Moderna, Inc. announced today they have agreed to transfer the marketing authorization in Japan for Moderna’s COVID-19 vaccine Spikevax™ vaccine from Takeda to Moderna effective August 2022. However, Takeda will continue to provide distribution support under the current national vaccination campaign for Moderna COVID-19 vaccines for a transitional period.